LEUKEMIA RESEARCH
ISSN:0145-2126

LEUKEMIA RESEARCH

LEUKEMIA RES
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:一般,3-6周
新锐分区:医学4区
年发文量:90
影响因子:2.2
JCR分区:Q3

基本信息

《白血病研究》是一本国际期刊,为所有参与血液恶性肿瘤基础和应用临床研究的医疗保健专业人员提供全面和最新的信息。编辑们鼓励提交与血液恶性肿瘤相关的文章。该杂志的范围包括报告细胞和分子生物学、遗传学、免疫学、流行病学、临床评价和这些疾病的治疗研究。
0145-2126SCIE/Scopus收录
2.2
2.3
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
HEMATOLOGY 血液学
4区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:HEMATOLOGY
SCIE
Q3
51/99
学科:ONCOLOGY
SCIE
Q3
217/328
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:HEMATOLOGY
SCIE
Q3
56/100
学科:ONCOLOGY
SCIE
Q3
222/328
81
90
7%容易一般,3-6周-医学-血液学
0%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
95.56%15.16%4.05%
CiteScore:3.70
SJR:0.784
SNIP:0.625
学科类别分区排名百分位
大类:Medicine
小类:Hematology
Q2
70 / 142
大类:Medicine
小类:Oncology
Q3
222 / 415
大类:Medicine
小类:Cancer Research
Q3
159 / 233

期刊高被引文献

Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.11.014
Programmed Cell Death Receptor (PD-1) Ligand (PD-L1) expression in Philadelphia chromosome-negative myeloproliferative neoplasms.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.02.010
A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post--polycythemia vera/essential thrombocythemia myelofibrosis (post--PV/ET MF).
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106272
A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS).
来源期刊:Leukemia researchDOI:10.1016/J.LEUKRES.2019.03.008
Identification of a novel, internal tRNA-derived RNA fragment as a new prognostic and screening biomarker in chronic lymphocytic leukemia, using an innovative quantitative real-time PCR assay.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106234
Prognostic significance of MYC oncoprotein expression on survival outcome in patients with acute myeloid leukemia with myelodysplasia related changes (AML-MRC).
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106194
A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.11.006
A retrospective study evaluating treatment patterns and survival outcomes in elderly patients with acute myeloid leukemia treated in the United States with either 7+3 or a hypomethylating agent.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.01.008
Efficacy outcomes in the treatment of older or medically unfit patients with acute myeloid leukaemia: A systematic review and meta-analysis.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.05.007
Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.02.008
Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106180
Improving risk-stratification of patients with chronic lymphocytic leukemia using multivariate patient similarity networks.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.02.005
The value of FDP/FIB and D-dimer/FIB ratios in predicting high-risk APL-related thrombosis.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.02.007
Long noncoding RNA MIAT promotes the progression of acute myeloid leukemia by negatively regulating miR-495.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106265
Low ferroportin expression in AML is correlated with good risk cytogenetics, improved outcomes and increased sensitivity to chemotherapy.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.02.011
Hepatic and cardiac and iron overload detected by T2* magnetic resonance (MRI) in patients with myelodisplastic syndrome: A cross-sectional study.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.12.001
Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.02.002
Relevant updates in systemic mastocytosis.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.04.001
Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106230
A review of thrombotic microangiopathies in multiple myeloma.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106195
Development of a novel fully-human anti-CD123 antibody to target acute myeloid leukemia.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106178
Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysis.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.04.005
Compound mutations involving T315I and P-loop mutations are the major components of multiple mutations detected in tyrosine kinase inhibitor resistant chronic myeloid leukemia.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.10.019
Ocular manifestations in acute lymphoblastic leukemia: A five-year cohort study of pediatric patients.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.11.017
The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.12.002
Predicting response to BET inhibitors using computational modeling: A BEAT AML project study
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.11.010
Expression of platelet parameters and platelet membrane glycoproteins in childhood Burkitt lymphoma.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106189
PRIMA-1MET cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106288
Pak1 gene functioned differentially in different BCR-ABL subtypes in leukemiagenesis and treatment response through STAT5 pathway.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.01.012
Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106266
Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106192
Clinical presentation and prognosis of immunoglobulin light-chain amyloidosis with high percentage of bone marrow plasma cells.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.04.002
Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106227
Tropolone-induced effects on the unfolded protein response pathway and apoptosis in multiple myeloma cells are dependent on iron.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.12.007
Expression analysis of genes located within the common deleted region of del(20q) in patients with myelodysplastic syndromes.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106175
Complex karyotype as a predictor of high-risk chronic lymphocytic leukemia: A single center experience over 12 years.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106218
Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106215
Risk and outcomes of second malignant neoplasms in chronic myeloid leukemia survivors.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.05.004
Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.01.002
High RASD1 transcript levels at diagnosis predicted poor survival in adult B-cell acute lymphoblastic leukemia patients.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.03.005
Clinical presentation and prognostic analysis of Chinese patients with systemic light chain amyloidosis with liver involvement.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106226
The role of high serum CXCL13 level in Waldenström macroglobulinemia.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.04.007
The upregulation of Pim kinases is essential in coordinating the survival, proliferation, and migration of KIT D816V-mutated neoplastic mast cells.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106166
Gene expression profiling by mRNA sequencing reveals dysregulation of core genes in Rictor deficient T-ALL mouse model.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106229
Replicative senescence of hematopoietic cells in patients with idiopathic cytopenia of undetermined significance.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.02.004
Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.12.012
Prognostic gene alterations and clonal changes in childhood B-ALL.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.05.009
The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900).
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.01.007
Naquotinib exerts antitumor activity in activated B-cell-like diffuse large B-cell lymphoma.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106286
High-dose etoposide and cyclophosphamide in adults and children with primary refractory and multiply relapsed acute leukaemias: The Royal Marsden experience.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106217

相关文章

2026年3月发布(新锐分区)
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
HEMATOLOGY 血液学
4区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
HEMATOLOGY 血液学
4区
ONCOLOGY 肿瘤学
4区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
HEMATOLOGY 血液学
4区
ONCOLOGY 肿瘤学
4区